The ZIVOLABS journal

Things worth knowing — before, during, after.

Short, plain-language guides on GLP-1 therapy and metabolic health, written and reviewed by ZIVOLABS doctors. No clickbait. No miracle promises.

Browse the full article library

Results

Showing 112 of 13
Comorbidity· 3 min

Asthma and weight loss

Obesity worsens asthma. Weight loss often reduces inhaler use.

22 May 2026
Comorbidity· 3 min

Thyroid disease and GLP-1

Hypothyroidism is common in India. It interacts with weight in specific ways — and with GLP-1.

21 May 2026
Comorbidity· 2 min

Snoring resolution with weight loss

Loud snoring isn't just an inconvenience. It can be the visible sign of sleep apnoea. Weight loss often resolves both.

18 May 2026
Comorbidity· 3 min

Reflux and obesity

Obesity is one of the biggest risk factors for chronic reflux. Weight loss helps fast.

17 May 2026
Comorbidity· 3 min

Migraine and weight management

There's a real bidirectional link between obesity and migraine. Treating one helps the other.

16 May 2026
Comorbidity· 4 min

Kidney function on GLP-1

GLP-1 is generally kidney-protective. Here's what to monitor and when to be cautious.

15 May 2026
Comorbidity· 4 min

Heart disease prevention

GLP-1 has been shown in large trials to reduce cardiovascular events. Here's what 'reduced' actually means.

14 May 2026
Comorbidity· 3 min

Knee pain and weight loss

Every kilo on your body is roughly 4 kilos of force through your knees when you walk. Losing 10 kg = 40 kg of load.

13 May 2026
Comorbidity· 4 min

Sleep apnoea and weight

If you snore loudly or wake up tired, this is worth investigating. GLP-1 helps directly.

12 May 2026
Comorbidity· 3 min

Cholesterol changes on GLP-1

Triglycerides drop dramatically. LDL changes modestly. HDL trends up slightly. The honest numbers.

11 May 2026
Comorbidity· 3 min

Hypertension and GLP-1

Weight loss almost always drops blood pressure. The medication doesn't directly lower BP — but the consequence is real.

10 May 2026
Comorbidity· 4 min

Fatty liver disease (NAFLD) and GLP-1

Non-alcoholic fatty liver affects ~30% of Indian adults. GLP-1 directly improves it.

9 May 2026
Page 1Next →
ZIVOLABS prescription GLP medication — vial (weekly injection) and bottle (daily oral dissolving tablets)
Now accepting patients

Not a diet. Not a gym plan.
Medical science. Finally in India.

  • Available as weekly injection or daily tablets
  • Around 15% average weight loss in major GLP‑1 trials — results vary*
  • Unlimited 24/7 support from our care team
  • Start with a ₹499 doctor consultation — refunded if you’re not eligible
  • Medication & ongoing care quoted separately — price shown before you pay
Am I qualified?
Takes 5 minutes. No commitment required.
NMC-registered doctors DCGI-approved medication Licensed pharmacy delivery
*Average weight loss seen in published GLP-1 RA trials over 68 weeks. Individual results vary. Read the medical disclaimer.